Exact Mass: 494.371953
Exact Mass Matches: 494.371953
Found 332 metabolites which its exact mass value is equals to given mass value 494.371953,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Makisteron A
Makisterone A is a steroid. Makisterone A is a natural product found in Rhodnius prolixus, Dysdercus cingulatus, and other organisms with data available.
28-Homobrassinolide
28-Homobrassinolide is found in brassicas. 28-Homobrassinolide is a constituent of chinese cabbage (Brassica rapa ssp. pekinensis) Constituent of chinese cabbage (Brassica rapa sspecies pekinensis). 28-Homobrassinolide is found in brassicas.
1-docosanoyl-glycero-3-phosphate
1-docosanoyl-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-docosanoyl-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-docosanoyl-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(22:0/0:0)
LysoPA(22:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(22:0/0:0), in particular, consists of one chain of behenic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
LysoPA(i-22:0/0:0)
LysoPA(i-22:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-22:0/0:0), in particular, consists of one chain of isodocosanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
N-Nervonoyl Glutamine
N-nervonoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Nervonic acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Nervonoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Nervonoyl Glutamine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
DG(8:0/18:2(10E,12Z)+=O(9)/0:0)
DG(8:0/18:2(10E,12Z)+=O(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/18:2(10E,12Z)+=O(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:2(10E,12Z)+=O(9)/8:0/0:0)
DG(18:2(10E,12Z)+=O(9)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(10E,12Z)+=O(9)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/18:2(10E,12Z)+=O(9))
DG(8:0/0:0/18:2(10E,12Z)+=O(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:2(10E,12Z)+=O(9)/0:0/8:0)
DG(18:2(10E,12Z)+=O(9)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/18:2(9Z,11E)+=O(13)/0:0)
DG(8:0/18:2(9Z,11E)+=O(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/18:2(9Z,11E)+=O(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:2(9Z,11E)+=O(13)/8:0/0:0)
DG(18:2(9Z,11E)+=O(13)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:2(9Z,11E)+=O(13)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/18:2(9Z,11E)+=O(13))
DG(8:0/0:0/18:2(9Z,11E)+=O(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:2(9Z,11E)+=O(13)/0:0/8:0)
DG(18:2(9Z,11E)+=O(13)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/18:3(10,12,15)-OH(9)/0:0)
DG(8:0/18:3(10,12,15)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/18:3(10,12,15)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:3(10,12,15)-OH(9)/8:0/0:0)
DG(18:3(10,12,15)-OH(9)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(10,12,15)-OH(9)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/18:3(10,12,15)-OH(9))
DG(8:0/0:0/18:3(10,12,15)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:3(10,12,15)-OH(9)/0:0/8:0)
DG(18:3(10,12,15)-OH(9)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/18:3(9,11,15)-OH(13)/0:0)
DG(8:0/18:3(9,11,15)-OH(13)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/18:3(9,11,15)-OH(13)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(18:3(9,11,15)-OH(13)/8:0/0:0)
DG(18:3(9,11,15)-OH(13)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:3(9,11,15)-OH(13)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/18:3(9,11,15)-OH(13))
DG(8:0/0:0/18:3(9,11,15)-OH(13)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(18:3(9,11,15)-OH(13)/0:0/8:0)
DG(18:3(9,11,15)-OH(13)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Calcium myristate
C28H54CaO4 (494.36477940000003)
It is used as a food additive .
2-O-(2-methylbutyryl)-3-O-acetyl-alpha-bisabolol-beta-D-fucopyranoside|2-O-<2-methylbutyryl>-3-O-acetyl-alpha-bisabolol-beta-D-fucopyranoside
(E)-1-acetoxy-1,4-dihydro-2-methyl-4-oxo-3-phytylnaphthalene
2-hydroxymethyl-2,3,22,23-tetrahydroxy-6,10,15,19,23-pentamethyl-6,10,14,18-tetracosatetraene
8beta-hydroxy-15-malonyloxy-18-angeloyloxy-ent-labdane
5alpha-pregn-6-ene-3beta,17alpha,20(S)-triol-3-O-beta-D-digitalopyranoside|teikagenin-3-O-beta-D-digitaloside
8beta-hydroxy-15-malonyloxy-18-senecioyloxy-ent-labdane
3beta-acetoxyglutina-5(10),6-dien-27,8alpha-olide|phyllenolide A
1beta,3beta,14alpha,20beta,22beta,25-hexahydroxy-5beta-ecdysteroid|aervecdysteroid C
2,3,5,22,23-pentahydroxy-2,6,10,15,19,23-hexamethyl-6,10,14,18-tetracosatetraene
(1S, 8E,12E)-1-((2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-4,9,13,17-tetramethyl octadeca-8,12,16-triene-1,4,5-triol|sapelenin I
20(R)-25-methoxyl-dammarane-3beta,6alpha,12beta,20-tetrol
1-(3,7-dimethylocta-2,6-dienyl)-6,6,10,10-tetramethyl-11-(2-methylpropanoyl)tetracyclo[7.3.1.13,11.03,7]tetradecane-2,12,14-trione|hypersampsone C
ethyl (22S,25R)-3alpha,12alpha,15alpha,22-tetrahydroxy-5beta-cholestan-26-oate
(2-{6-[3-(2-dimethylamino-ethyl)-indol-2-yl]-7,7,9-trimethyl-6a,7,8,10a-tetrahydro-6H-isoindolo[2,1-a]indol-11-yl}-ethyl)-methyl-amine|4-Methyl-isoborreverin|Methyl-4-Isoborreverin
(8R,9S,22R)-3-ethoxy-3-oxo-9,19-cyclo-3,4-secolanosta-4(28),6,24-trien-26-oic acid 22,26-lactone
(2S,3R,5R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,5R)-2,3,6-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
(2S,3R,10R,13R,14S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,5R)-2,3,5-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
(2S,3R,5R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,5R)-2,3,6-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
(2S,3R,10R,13R,14S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,5R)-2,3,5-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one [IIN-based on: CCMSLIB00000847804]
(2S,3R,10R,13R,14S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,5R)-2,3,5-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one [IIN-based: Match]
(5Z,7E)-(1S,3R)-24,24-difluoro-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
C30H48F2O3 (494.3571321999999)
(5Z,7E)-(1S,3R)-18-[m-(1-hydroxy-1-methylethyl)-benzyloxy]-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol
Atocalcitol
Isohomobrassinolide
Cyathsterone D
Heptaethylene glycol monododecyl ether
D019999 - Pharmaceutical Solutions > D012597 - Sclerosing Solutions D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D013501 - Surface-Active Agents > D003902 - Detergents D001697 - Biomedical and Dental Materials D002317 - Cardiovascular Agents
benzyldimethyl[3-[(1-oxoisooctadecyl)amino]propyl]ammonium chloride
tris(2-(2-Butoxyethoxy)ethyl)orthoborate
C24H51BO9 (494.36259459999997)
benzyldimethyl[3-[(1-oxooctadecyl)amino]propyl]ammonium chloride
Guanethidine sulfate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
Homobrassinolide
28-Homobrassinolide is a phytosteroid. 28-Homobrassinolide can be used for the research of cholesterol and glucose homeostasis[1].
trimethyl-3-[(1-oxooctadecyl)amino]propylammonium methyl sulphate
[(2R)-1-hydroxy-3-phosphonooxypropan-2-yl] docosanoate
2-[[(2R)-3-[(Z)-hexadec-9-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C24H49NO7P+ (494.32464740000006)
[(2S)-1-hydroxy-3-octanoyloxypropan-2-yl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate
[(2S)-3-hydroxy-2-octanoyloxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate
[(2R)-2-hydroxy-3-octanoyloxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate
[(2S)-2-hydroxy-3-octanoyloxypropyl] (10E,12E,15E)-9-hydroxyoctadeca-10,12,15-trienoate
[(2S)-1-hydroxy-3-octanoyloxypropan-2-yl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate
[(2S)-3-hydroxy-2-octanoyloxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate
[(2R)-2-hydroxy-3-octanoyloxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate
[(2S)-2-hydroxy-3-octanoyloxypropyl] (9E,11E,15E)-13-hydroxyoctadeca-9,11,15-trienoate
2-[[2-[(E)-hexadec-9-enoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C24H49NO7P+ (494.32464740000006)
[3-Carboxy-2-[13-(3,4-dimethyl-5-propylfuran-2-yl)tridecanoyloxy]propyl]-trimethylazanium
C29H52NO5+ (494.38452820000003)
[3-Carboxy-2-[11-(3,4-dimethyl-5-pentylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium
C29H52NO5+ (494.38452820000003)
2-[[3-[(E)-hexadec-9-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C24H49NO7P+ (494.32464740000006)
(-)-Duryne D
An enyne that is (4E,13Z,19Z,30E)-tetratriaconta-4,13,19,30-tetraene-1,33-diyne substituted by hydroxy groups at positions 3 and 32 (the 3R,32R-stereoisomer). It has been isolated from the marine sponge Petrosia.
Guanethidine bisulfate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
3-(4-ethoxyphenyl)-1-[3-(4-morpholinyl)propyl]-1-[(1-propyl-3,4-dihydro-2H-quinolin-6-yl)methyl]urea
(2S,3R,10R,13R,14S)-2,3,14-Trihydroxy-10,13-dimethyl-17-[(2R,3R,5R)-2,3,5-trihydroxy-5,6-dimethylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
O-[1-O-[(E)-9-Hexadecenoyl]-L-glycero-3-phospho]choline
C24H49NO7P+ (494.32464740000006)
2-[[(2R)-2-[(Z)-hexadec-9-enoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C24H49NO7P+ (494.32464740000006)
2-[[(2R)-3-[(Z)-heptadec-1-enoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C25H53NO6P+ (494.36103080000004)
[17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
C29H50O4S (494.34296200000006)
[3-Hydroxy-2-(nonanoylamino)decyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(propanoylamino)hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
(2-Acetamido-3-hydroxyheptadecyl) 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(octanoylamino)undecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Hexanoylamino)-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Butanoylamino)-3-hydroxypentadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(pentanoylamino)tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Heptanoylamino)-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Decanoylamino)-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-carboxy-2-[(14E,16E)-tricosa-14,16-dienoyl]oxypropyl]-trimethylazanium
C30H56NO4+ (494.42091160000007)
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (Z)-tetradec-9-enoate
[3-Hydroxy-2-(undecanoylamino)octyl] 2-(trimethylazaniumyl)ethyl phosphate
(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-13,16,19,22,25,28,31-heptaenoic acid
(1-hydroxy-3-octanoyloxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate
(1-hydroxy-3-nonanoyloxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate
(1-hydroxy-3-undecanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-tetradec-9-enoate
(1-decanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
(1-heptanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate
(1-hydroxy-3-propanoyloxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate
(1-hexanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate
(1-hydroxy-3-pentanoyloxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate
2-[[3-[(Z)-hexadec-9-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C24H49NO7P+ (494.32464740000006)
(3-hydroxy-2-undecanoyloxypropyl) (4E,7E)-hexadeca-4,7-dienoate
[1-carboxy-3-[2-hydroxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
2-[[2-[(Z)-hexadec-4-enoyl]oxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C24H49NO7P+ (494.32464740000006)
2-[[(2R)-3-[(E)-hexadec-7-enoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C24H49NO7P+ (494.32464740000006)
[(2S)-1-decanoyloxy-3-hydroxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate
[(2S)-2-decanoyloxy-3-hydroxypropyl] (9E,12E)-heptadeca-9,12-dienoate
[1-carboxy-3-[2-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
2-[[2-acetyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C24H49NO7P+ (494.32464740000006)
2-[[3-[(Z)-heptadec-9-enoxy]-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C25H53NO6P+ (494.36103080000004)
2-[hydroxy-[2-propanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
C24H49NO7P+ (494.32464740000006)
2,3,14-Trihydroxy-10,13-dimethyl-17-(2,3,6-trihydroxy-5,6-dimethylheptan-2-yl)-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
DG(27:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(3z,3as,5ar,7s,9ar,9bs)-3-[(3e,5e)-6,10-dimethyl-7-oxoundeca-3,5,9-trien-2-ylidene]-3a,6,6,9a-tetramethyl-2-oxo-octahydrocyclopenta[a]naphthalen-7-yl acetate
(1s,2r,4r)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl (6ar,10ar)-1-hydroxy-6,6,9-trimethyl-3-pentyl-6ah,7h,8h,10ah-benzo[c]isochromene-2-carboxylate
1-isopropyl-4-methylcyclohex-3-en-1-yl 1-hydroxy-6,6,9-trimethyl-3-pentyl-6ah,7h,8h,10ah-benzo[c]isochromene-2-carboxylate
1-(2,3-dihydroxy-5,6-dimethylheptan-2-yl)-3a,7,8,10-tetrahydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
(3r,4e,30e,32r)-tetratriaconta-4,13,19,30-tetraen-1,33-diyne-3,32-diol
(1r,2s,4s)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl (6ar,10ar)-1-hydroxy-6,6,9-trimethyl-3-pentyl-6ah,7h,8h,10ah-benzo[c]isochromene-2-carboxylate
[(2r,3r,4s,5r,6s)-6-{[(1s,4s,4ar,8as)-1,6-dimethyl-4-[(2r)-6-methylhept-5-en-2-yl]-3,4,4a,7,8,8a-hexahydro-2h-naphthalen-1-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl acetate
ethyl 3-[(1s,4r,5r,8s,9r,12s,13r)-4,8-dimethyl-5-[(1s)-1-[(2r)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-12-(prop-1-en-2-yl)tetracyclo[7.5.0.0¹,¹³.0⁴,⁸]tetradec-10-en-13-yl]propanoate
(1r,4e,8e,12r,13r)-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,9,13,17-tetramethyloctadeca-4,8,16-triene-1,12,13-triol
(1s,3as,5ar,7r,8s,9ar,9br,10r,11ar)-1-[(2r,3r)-2,3-dihydroxy-5,6-dimethylheptan-2-yl]-3a,7,8,10-tetrahydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
6-{3,5,5a,7-tetrahydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl}-3-isopropylheptanoic acid
3-{[5-(2-hydroxy-2,5,8a-trimethyl-5-{[(3-methylbut-2-enoyl)oxy]methyl}-hexahydro-1h-naphthalen-1-yl)-3-methylpentyl]oxy}-3-oxopropanoic acid
ethyl 3-{4,8-dimethyl-5-[1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-12-(prop-1-en-2-yl)tetracyclo[7.5.0.0¹,¹³.0⁴,⁸]tetradec-10-en-13-yl}propanoate
3-(3,4-dihydroxy-5-methoxyphenyl)propyl 3-hydroxy-11-methyloctadecanoate
(2s,3r,4s,5s,6r)-4-(acetyloxy)-5-hydroxy-6-methyl-2-{[(2r)-6-methyl-2-[(1s)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-yl]oxy}oxan-3-yl (2r)-2-methylbutanoate
25- deoxysodium makisterone A
{"Ingredient_id": "HBIN004610","Ingredient_name": "25- deoxysodium makisterone A","Alias": "NA","Ingredient_formula": "C28H46O7","Ingredient_Smile": "CC(CC(C(C)(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O)O)C(C)(C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "40221","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2S,3R,4S,5S,6R)-2-[[(3S,8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-6-methyloxane-3,5-diol
{"Ingredient_id": "HBIN006655","Ingredient_name": "(2S,3R,4S,5S,6R)-2-[[(3S,8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-6-methyloxane-3,5-diol","Alias": "(2S,3R,4S,5S,6R)-2-[[(3S,8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-6-methyl-tetrahydropyran-3,5-diol; (2S,3R,4S,5S,6R)-2-[[(3S,8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-6-methyl-oxane-3,5-diol; (2S,3R,4S,5S,6R)-2-[[(3S,8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-6-methyltetrahydropyran-3,5-diol","Ingredient_formula": "C28H46O7","Ingredient_Smile": "NA","Ingredient_weight": "494.66","OB_score": "21.59533771","CAS_id": "116709-66-1","SymMap_id": "SMIT07406","TCMID_id": "NA","TCMSP_id": "MOL005682","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}